To triage a medication error, suspected poisoning, adverse reaction, and missing medicine, predeclare observable event categories and qualified routes. A wrong medicine, wrong dose, repeated or missed dose, suspected poisoning, acute symptom, lost supply, damaged package, refill failure, and inaccessible instruction can require different actions. Protect Mina first, preserve communication, use current medical, poison, pharmacy, or emergency directions, and document without delaying urgent help.

Define Mina's page-specific medication-support decision

For medication-event triage, define the person, medicine-related question, current source, setting, communication, qualified medical or pharmacy route, authorized supporter, release gate, stop rule, backup, and outcome. Keep exposure facts, symptoms, missing supply, refill status, administration record, medical advice, poison advice, emergency action, and later clinical review as separate evidence states.

Protect Mina's essential access and urgent routes

Mina's plan keeps AAC, prescribed care, emergency and poison help, hydration, food, bathroom access, mobility, sleep, pain care, privacy, and lawful withdrawal from nonurgent practice protected. This plan cannot create prescribing, dispensing, administration, pharmacy, payer, emergency, privacy, or legal authority.

Build Mina's medication event triage and handoff matrix

Create one versioned record for home, program, community, travel, and pharmacy routes. Include Mina's priorities, current sources, medicine identifiers, questions, communication, authority, administration roles, storage, supply, refills, handoffs, supporters, urgent routes, privacy, assessment, incidents, restrictions, missingness, and review. Use a trigger-to-action matrix with medicine, person, event, observable facts, immediate route, information requested by that route, prohibited improvisations, reporter, owner, timestamp, and final disposition.

Validate Mina's counts and denominators

Reproduce nine supporters times ten cases equals 90, with 72 initial passes, 86 after rehearsal, and four named open actions.

Connect Mina's evidence to a bounded action

The coordinator withholds only affected assignments, corrects the four routes with qualified owners, and keeps immediate medical action ahead of routine clinical approval or data completion.

Work through Mina's example

Nine supporters complete ten fictional tabletop decisions each, producing 90 scored actions. Seventy-two pass initially. After focused rehearsal, 86 pass. Four remain open: one suspected-poisoning route, one severe-symptom emergency threshold, one lost-controlled-item report, and one after-hours pharmacy handoff. Preserve every planned, held, current, eligible, tested, completed, messaged, and reviewed unit with source version, ordinary support, person response, partner action, restriction, incident, and endpoint. This fictional example supplies no medical order, pharmacy approval, administration authority, treatment effect, or promised outcome.

Address Mina's main interpretation risk

Eighty-six of 90 measures tabletop decisions. It cannot prove medical safety, poison severity, pharmacy access, replacement approval, or live performance. Four unresolved actions remain holds. Review source currency, access, communication, health context, supporter behavior, environment, instruction, restrictions, incidents, missingness, and design strength separately.

Set Mina's ABA and medication boundaries

Mina's medication event triage and handoff matrix uses the CASP public summary only for high-level ABA behavioral-health-treatment scope for autistic people. The current BACB Ethics Code addresses competence, collaboration, consent and assent when applicable, medical needs, assessment, risk, confidentiality, documentation, and evaluation for covered people. Diagnosis, prescribing, dispensing, administration, pharmacy, payer, privacy, poison, and emergency authority remain with qualified owners.

Keep Mina's communication available

The ASHA AAC portal says AAC users should always have access to their communication tools or devices. Mina's primary system and tested backup stay available when reviewing information, asking, reporting symptoms or errors, contacting a pharmacy or clinician, completing a handoff, and stopping nonurgent practice. A supporter may facilitate access without inventing Mina's message.

Use a current medication list for Mina's questions

For Mina, FDA medication-list guidance supports a list that includes prescription and over-the-counter medicines, vitamins, and supplements and is updated when medicines or doses change. Preserve source and update date, discrepancies, allergies when documented by the qualified source, questions, and the person who resolves them. Never change an order from memory.

Route Mina's medicine-use questions to qualified owners

FDA medicine-use guidance encourages people to know their medicines, follow current directions, and ask health professionals questions. It is general consumer guidance rather than a patient-specific order. Mina's team uses it to build accessible questions and verification steps while leaving medicine selection, dose, timing, interactions, side effects, and changes to qualified medical and pharmacy professionals.

Put suspected poisoning ahead of Mina's teaching data

HRSA Poison Help provides the U.S. Poison Help number, 1-800-222-1222, around the clock and describes information to have ready. Current expert instructions govern the event. Mina's supporter preserves the container and known facts when safe, follows the qualified route, and avoids delaying the call to complete a score or seek routine approval.

Keep Mina's emergency route direct

The SAMHSA crisis-help page routes anyone in danger or experiencing a medical emergency in the United States to 911 or the nearest emergency room. It does not diagnose Mina or decide whether a particular symptom is medication-related. The plan uses current person-specific medical and emergency instructions and keeps later clinical review separate.

Make medication communication effective for Mina

DOJ effective-communication guidance explains that covered entities choose aids and services based on the person's usual communication method and the context, length, complexity, and nature of the exchange. A medication conversation can be complex and consequential. Mina's team records the requested method, effective backup, interpreter or aid route, response time, and unresolved access barrier.

Verify representative authority for Mina

For Mina, HHS personal-representative guidance makes applicable law the source for representative status and its scope, including minor-specific rules and certain safety exceptions. A family relationship, emergency-contact label, medication pickup, or supporter role does not create universal decision or disclosure authority.

Keep involved-person communication distinct for Mina

For Mina, HHS guidance on family and others involved in care describes when a covered provider may share directly relevant information with an involved person under that pathway's conditions. The route does not automatically make the person a legal representative or authorize every decision. Record scope, objection, professional judgment when applicable, and change triggers separately.

Choose Mina's next review trigger

Retrain after a medication, label, dose, symptom plan, poison route, pharmacy contact, setting, supporter, incident, or Mina communication change. Record the qualified owner, source, effective date, medicine and setting scope, communication arrangement, support result, accessible explanation, urgent boundary, complaint route, and reassessment date.

Close Mina's medication-support plan

Review the medication event triage and handoff matrix with Mina, the qualified behavior analyst, chosen or authorized supporters as applicable, and the specialists named in the manifest. Confirm that prescribing, pharmacy, administration, payer, privacy, urgent response, assessment, teaching, restrictions, incidents, and follow-up remain separate; every denominator is reproducible; AAC, privacy, essential care, emergency help, and withdrawal from nonurgent practice remain protected; and conclusions stay bounded to tested conditions. Keep this page draft and noindex until every required review is complete.

Related resources

Sources